Last Close
Feb 03  •  04:00PM ET
10.69
Dollar change
0.00
Percentage change
0.00
%
Index- P/E38.19 EPS (ttm)0.28 Insider Own19.52% Shs Outstand19.78M Perf Week0.38%
Market Cap262.79M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float19.78M Perf Month0.47%
Enterprise Value261.47M PEG- EPS next Q- Inst Own75.59% Short Float0.26% Perf Quarter1.14%
Income6.88M P/S- EPS this Y- Inst Trans- Short Ratio1.03 Perf Half Y2.30%
Sales0.00M P/B1.36 EPS next Y- ROA6.82% Short Interest0.05M Perf YTD1.04%
Book/sh7.85 P/C197.59 EPS next 5Y- ROE7.13% 52W High10.85 -1.47% Perf Year-
Cash/sh0.05 P/FCF- EPS past 3/5Y- - ROIC3.56% 52W Low9.96 7.33% Perf 3Y-
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility0.65% 0.54% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM- Oper. Margin- ATR (14)0.06 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.21 Sales Y/Y TTM- Profit Margin- RSI (14)59.29 Recom-
Dividend Gr. 3/5Y- - Current Ratio1.21 EPS Q/Q3909.52% SMA200.62% Beta-0.11 Target Price-
Payout0.00% Debt/Eq0.00 Sales Q/Q- SMA500.83% Rel Volume0.00 Prev Close10.69
Employees3 LT Debt/Eq0.00 Earnings- SMA2002.36% Avg Volume49.64K Price10.69
IPODec 16, 2024 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume206 Change0.00%
Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.